The findings were presented virtually during the Society of Nuclear Medicine and Molecular Imaging's 2021 Annual Meeting.

Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. That, in fact, is already occurring. One strategy gaining currency among interventionalists, particularly those in Europe, is to try a high-pressure balloon first in cases of moderately severe calcification and, if the device fails to fully expand, re-enter the vessel with atherectomy. 

The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 

A record 31 million are covered under health insurance through the Affordable Care Act, the White House announced in a report. 

Sifting the literature for real-world challenges thwarting adoption of clinical AI across medicine, a team of biomedical engineers and computer scientists has identified and fleshed out an exemplary use case.

The Food and Drug Administration has approved a new drug that claims to slow the progression of Alzheimer’s disease. The drug is the first approved for Alzheimer’s disease since 2003.

The vast majority of healthcare executives say digital transformation across their organizations is accelerating, according to a recent survey of 399 executives from six countries.

Virtual care, remote patient monitoring and AI-based research are three specific topics the groups are expected to discuss.